Valeant PharmaceuticalsDirector, Strategic Accounts (DSO/Group Practice)
Jun. 2004 - Apr. 2017Bridgewater, NJSelling responsibilities and product launches included: Arestin broad-spectrum antibiotic, Oral CDX oncology diagnostics, Ossix Plus regenerative bone and tissue biologics, Dysport dermatological injection, Tramadol, OnSet and Oraqix anesthetics, Neutrasal Xerostomia rinse. Successfully sold product portfolio through both a specialty pharmaceutical model and an HCP direct buy & bill model. Formulated account-based business strategies, including sales forecasts, budget allocations, strategy development, and tactical pull-through. Managed and cross-functionally collaborated with the internal marketing, educational and legal teams, regarding customer contract negotiation, preparation, and execution. Built solid relationships with industry key opinion leaders (KOL) and leveraged them in nationwide speaker programs, to increase clinical confidence and product utilization. Call points ranged from practice level clinicians to C-suite and Middle management in the largest Dental Service Organizations in the United States. Responsibilities included RFP construction, high level presentation and strategic business planning to solidify and grow existing business.